-
公开(公告)号:US20110092512A1
公开(公告)日:2011-04-21
申请号:US12900621
申请日:2010-10-08
申请人: Jean Ackermann , Stephan Brugger , Aurelia Conte , Daniel Hunziker , Werner Neidhart , Matthias Nettekoven , Tanja Schulz-Gasch , Stanley Wertheimer
发明人: Jean Ackermann , Stephan Brugger , Aurelia Conte , Daniel Hunziker , Werner Neidhart , Matthias Nettekoven , Tanja Schulz-Gasch , Stanley Wertheimer
IPC分类号: A61K31/501 , C07D209/54 , A61K31/403 , C07D403/12 , A61K31/506 , A61K31/497 , C07D401/04 , A61K31/4439 , C07D417/08 , C07D403/08 , A61K31/4192 , A61K31/4155 , C07D413/08 , A61K31/422 , A61P3/10 , A61P3/04 , A61P3/06 , A61P1/16 , A61P9/00 , A61P9/10 , A61P29/00
CPC分类号: C07D209/54 , C07D401/06 , C07D401/12 , C07D403/12 , C07D405/04 , C07D405/12 , C07D409/12 , C07D413/12
摘要: The present invention relates to compounds of formula (I) as well as pharmaceutically acceptable salts thereof. The are useful as HSL inhibitors and may, for example, be used in treatment of diabetes, metabolic syndrome, dyslipidemia, atherosclerosis, and obesity.
摘要翻译: 本发明涉及式(I)化合物及其药学上可接受的盐。 它们可用作HSL抑制剂,并且可以例如用于治疗糖尿病,代谢综合征,血脂异常,动脉粥样硬化和肥胖症。
-
公开(公告)号:US08440710B2
公开(公告)日:2013-05-14
申请号:US12900621
申请日:2010-10-08
申请人: Jean Ackermann , Stephan Brugger , Aurelia Conte , Daniel Hunziker , Werner Neidhart , Matthias Nettekoven , Tanja Schulz-Gasch , Stanley Wertheimer
发明人: Jean Ackermann , Stephan Brugger , Aurelia Conte , Daniel Hunziker , Werner Neidhart , Matthias Nettekoven , Tanja Schulz-Gasch , Stanley Wertheimer
IPC分类号: A61K31/4015 , C07D209/96
CPC分类号: C07D209/54 , C07D401/06 , C07D401/12 , C07D403/12 , C07D405/04 , C07D405/12 , C07D409/12 , C07D413/12
摘要: The present invention relates to compounds of formula (I) as well as pharmaceutically acceptable salts thereof. The are useful as HSL inhibitors and may, for example, be used in treatment of diabetes, metabolic syndrome, dyslipidemia, atherosclerosis, and obesity.
摘要翻译: 本发明涉及式(I)化合物及其药学上可接受的盐。 它们可用作HSL抑制剂,并且可以例如用于治疗糖尿病,代谢综合征,血脂异常,动脉粥样硬化和肥胖症。
-
公开(公告)号:US20120041013A1
公开(公告)日:2012-02-16
申请号:US13204743
申请日:2011-08-08
申请人: Jean Ackermann , Aurelia Conte , Daniel Hunziker , Werner Neidhart , Matthias Nettekoven , Tanja Schulz-Gasch , Stanley Wertheimer
发明人: Jean Ackermann , Aurelia Conte , Daniel Hunziker , Werner Neidhart , Matthias Nettekoven , Tanja Schulz-Gasch , Stanley Wertheimer
IPC分类号: A61K31/438 , A61P3/10 , A61P3/04 , C07D471/10
CPC分类号: C07D471/10
摘要: The invention provides novel compounds having the general formula (I) wherein R1, R2 and n are as described herein, compositions including the compounds and methods of using the compounds. The compounds are useful as inhibitors of hormone sensitive lipase (HSL) for the treatment of diabetes, metabolic syndrome and obesity.
摘要翻译: 本发明提供具有通式(I)的新化合物,其中R 1,R 2和n如本文所述,包括该化合物的组合物和使用该化合物的方法。 该化合物可用作激素敏感性脂肪酶(HSL)的抑制剂,用于治疗糖尿病,代谢综合征和肥胖症。
-
公开(公告)号:US08389539B2
公开(公告)日:2013-03-05
申请号:US12951095
申请日:2010-11-22
申请人: Jean Ackermann , Aurelia Conte , Daniel Hunziker , Werner Neidhart , Matthias Nettekoven , Tanja Schulz-Gasch , Stanley Wertheimer
发明人: Jean Ackermann , Aurelia Conte , Daniel Hunziker , Werner Neidhart , Matthias Nettekoven , Tanja Schulz-Gasch , Stanley Wertheimer
IPC分类号: A61K31/438 , C07D221/20
CPC分类号: C07D471/10
摘要: Compounds of formula (I) as well as pharmaceutically acceptable salts thereof can be used in the form of pharmaceutical compositions, wherein R1, R2, R3 and n have the significance given in claim 1.
摘要翻译: 式(I)化合物及其药学上可接受的盐可以以药物组合物的形式使用,其中R1,R2,R3和n具有权利要求1中给出的含义。
-
公开(公告)号:US20110130417A1
公开(公告)日:2011-06-02
申请号:US12951095
申请日:2010-11-22
申请人: Jean Ackermann , Aurelia Conte , Daniel Hunziker , Werner Neidhart , Matthias Nettekoven , Tanja Schulz-Gasch , Stanley Wertheimer
发明人: Jean Ackermann , Aurelia Conte , Daniel Hunziker , Werner Neidhart , Matthias Nettekoven , Tanja Schulz-Gasch , Stanley Wertheimer
IPC分类号: A61K31/438 , C07D471/10 , A61P3/10
CPC分类号: C07D471/10
摘要: Compounds of formula (I) as well as pharmaceutically acceptable salts thereof can be used in the form of pharmaceutical compositions, wherein R1, R2, R3 and n have the significance given in claim 1.
摘要翻译: 式(I)化合物及其药学上可接受的盐可以以药物组合物的形式使用,其中R1,R2,R3和n具有权利要求1中给出的含义。
-
公开(公告)号:US20100292212A1
公开(公告)日:2010-11-18
申请号:US12772246
申请日:2010-05-03
申请人: Jean Ackermann , Aurelia Conte , Daniel Hunziker , Werner Neidhart , Matthias Nettekoven , Tanja Schulz-Gasch , Stanley Wertheimer
发明人: Jean Ackermann , Aurelia Conte , Daniel Hunziker , Werner Neidhart , Matthias Nettekoven , Tanja Schulz-Gasch , Stanley Wertheimer
IPC分类号: A61K31/438 , C07D471/10 , A61K31/5377 , A61K31/501 , A61K31/55 , A61K31/4709 , A61P3/06 , A61P3/04 , A61P3/10 , A61P9/10
CPC分类号: C07D471/10
摘要: The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein n, m, A, R1 and R2 have the significance given in the description. The compounds are useful as HSL inhibitors and may be used in the treatment or prophylaxis of diabetes, dyslipidemia, atherosclerosis or obesity.
摘要翻译: 本发明涉及式(I)化合物及其药学上可接受的盐,其中n,m,A,R 1和R 2具有在说明书中给出的含义。 该化合物可用作HSL抑制剂,可用于治疗或预防糖尿病,血脂异常,动脉粥样硬化或肥胖。
-
公开(公告)号:US08470843B2
公开(公告)日:2013-06-25
申请号:US13180582
申请日:2011-07-12
申请人: Jean Ackermann , Aurelia Conte , Daniel Hunziker , Werner Neidhart , Matthias Nettekoven , Tanja Schulz-Gasch , Stanley Wertheimer
发明人: Jean Ackermann , Aurelia Conte , Daniel Hunziker , Werner Neidhart , Matthias Nettekoven , Tanja Schulz-Gasch , Stanley Wertheimer
IPC分类号: A61K31/438 , C07D221/20 , C07D471/10
CPC分类号: C07D471/10
摘要: The invention provides novel compounds having the general formula (I) wherein R1, R2, R3 and A are as described herein, compositions including the compounds and methods of using the compounds.
摘要翻译: 本发明提供具有通式(I)的新化合物,其中R 1,R 2,R 3和A如本文所述,包括该化合物的组合物和使用该化合物的方法。
-
公开(公告)号:US08329904B2
公开(公告)日:2012-12-11
申请号:US12772246
申请日:2010-05-03
申请人: Jean Ackermann , Aurelia Conte , Daniel Hunziker , Werner Neidhart , Matthias Nettekoven , Tanja Schulz-Gasch , Stanley Wertheimer
发明人: Jean Ackermann , Aurelia Conte , Daniel Hunziker , Werner Neidhart , Matthias Nettekoven , Tanja Schulz-Gasch , Stanley Wertheimer
IPC分类号: C07D215/00 , C07D273/00
CPC分类号: C07D471/10
摘要: The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein n, m, A, R1 and R2 have the significance given in the description. The compounds are useful as HSL inhibitors and may be used in the treatment or prophylaxis of diabetes, dyslipidemia, atherosclerosis or obesity.
摘要翻译: 本发明涉及式(I)化合物及其药学上可接受的盐,其中n,m,A,R 1和R 2具有在说明书中给出的含义。 该化合物可用作HSL抑制剂,可用于治疗或预防糖尿病,血脂异常,动脉粥样硬化或肥胖。
-
公开(公告)号:US20110257212A1
公开(公告)日:2011-10-20
申请号:US13082433
申请日:2011-04-08
申请人: Jean Ackermann , Aurelia Conte , Daniel Hunziker , Werner Neidhart , Matthias Nettekoven , Tanja Schulz-Gasch , Stanley Wertheimer
发明人: Jean Ackermann , Aurelia Conte , Daniel Hunziker , Werner Neidhart , Matthias Nettekoven , Tanja Schulz-Gasch , Stanley Wertheimer
IPC分类号: A61K31/438 , A61P3/00 , C07D471/10
CPC分类号: C07D471/10
摘要: The invention provides novel compounds having the general formula (I) wherein R1, R2 and A are as described herein, compositions including the compounds and methods of using the compounds. The compounds inhibit hormone sensitive lipase (HSL) and may be used in the treatment of diabetes, metabolic syndrome, and obesity.
摘要翻译: 本发明提供具有通式(I)的新化合物,其中R 1,R 2和A如本文所述,包括该化合物的组合物和使用该化合物的方法。 该化合物抑制激素敏感性脂肪酶(HSL),可用于治疗糖尿病,代谢综合征和肥胖症。
-
公开(公告)号:US20120015970A1
公开(公告)日:2012-01-19
申请号:US13180582
申请日:2011-07-12
申请人: Jean Ackermann , Aurelia Conte , Daniel Hunziker , Werner Neidhart , Matthias Nettekoven , Tanja Schulz-Gasch , Stanley Wertheimer
发明人: Jean Ackermann , Aurelia Conte , Daniel Hunziker , Werner Neidhart , Matthias Nettekoven , Tanja Schulz-Gasch , Stanley Wertheimer
IPC分类号: A61K31/438 , A61P3/10 , A61P3/00 , A61P1/16 , A61P9/10 , A61P3/04 , A61P9/00 , A61P29/00 , C07D471/10 , A61P3/06
CPC分类号: C07D471/10
摘要: The invention provides novel compounds having the general formula (I) wherein R1, R2, R3 and A are as described herein, compositions including the compounds and methods of using the compounds.
摘要翻译: 本发明提供具有通式(I)的新化合物,其中R 1,R 2,R 3和A如本文所述,包括该化合物的组合物和使用该化合物的方法。
-
-
-
-
-
-
-
-
-